Biomedical Advanced Research and Development Authority
Government departmentWikipedia
15
MENTIONS
8
EPISODES
8
PODCASTS
Search complete. 15 mentions across 8 episodes found for "Biomedical Advanced Research and Development Authority".
Nov 3, 2026
Paul PottingerHOST
We have reports on the 28th of October.
Paul PottingerHOST
There is an international research organization called IAVI, which was happy to announce that it recently received a large gift, 36 million US dollars, from the US Biomedical Advanced Research and Development Authority.
Paul PottingerHOST
to help get some of these clinical trials on the ground in DRC vaccine trials against Bundabugio.
Paul PottingerHOST
In fact, this award from the U.S. Biomedical Advanced Research Development Authority could potentially be worth up to $99 million if things go well and they meet certain metrics, as I understand it, from the original initial $36 million award.
Peter BregginHOST
And, um, I realized I'd found the plan, and key people were in it.
Peter BregginHOST
The head of BARDA was, uh, uh, was in it.
Manny GarciaGUEST
Hmm.
Manny GarciaGUEST
Yep.
Peter BregginHOST
The new head, new head of BARDA, the, that funneled all the money from the taxpayers to the drug companies as they started to do things with the new COVID vaccine.
Peter BregginHOST
He, they paid him off and gave him enough money to ensure a profit right from the start, right out of the checkbook of the government.
Peter BregginHOST
Get Moderna going, get Pfizer going, get them all going, and, um, was a tremendous boom.
Peter BregginHOST
Doc had all planned ahead, and they picked the head of BARDA who would be the one giving out the money, and he was involved in the original planning, just working with him, being educated by him.
Ron ElfenbeinGUEST
100% of the profits goes to the drug manufacturers.
Alix MayerHOST
And it was billions of dollars in BARDA funds.
Alix MayerHOST
B-A-R-E-A.
Alix MayerHOST
Yeah.
Sasha LatypovaGUEST
And for the biomedical research, ostensibly, but it's making these monstrous countermeasures that have no liability whatsoever.
Sasha LatypovaGUEST
And funding through BARDA, which is the direct mechanism.
Sasha LatypovaGUEST
They call it the Bank of BARDA.
Sasha LatypovaGUEST
BARDA funds countermeasures development directly.
Sasha LatypovaGUEST
And so a lot of money, I've lost count, but it's over a billion dollars already has been committed to the variety of the mRNA vaccine efforts.
Sasha LatypovaGUEST
And they're going to fund BARDA even more to the tune of 66 or 67 billion dollars.
Sasha LatypovaGUEST
What for? They're justifying this by saying, well, we have epidemics.
Sasha LatypovaGUEST
And when you look at the actual numbers, they're laughable.
Carmel FisherHOST
Excellent and congratulations.
Carmel FisherHOST
With the recent elevation of cell and gene theory development in the U.S. Biomedical Advanced Research and Development Authority's strategic framework, they go by BARDA, or B-A-R-D-A, how does Kalidi position itself to potentially benefit from increased government focus in this space?
Stephen ThesingGUEST
We have over the past several years, I should say our CEO and our team together have focused energy developing relationships on both sides of the aisle.
Stephen ThesingGUEST
Cancer is a nonpartisan issue.
Stéphane BancelGUEST
So it's true that in the US, the funding has been challenging.
Stéphane BancelGUEST
As you said, we, we lost a big BARDA grant, uh, which was regrettable because BARDA in the past has partnered with Moderna.
Stéphane BancelGUEST
And OWS, Operation Warp Speed, was basically funded through BARDA.
Stéphane BancelGUEST
Uh, and we've done a lot of work before the pandemic, like other companies, to kind of prepare the country and prepare the world in case of bad outcomes like, like a pandemic or a big outbreak.
Stéphane BancelGUEST
Uh, the good news is we work with other agencies like CEPI in the UK to be able to keep that study going.
speaker_0HOST
Despite setbacks like Syndax Pharmaceuticals' noctemvo fibrosis program discontinuation due to unmet trial endpoints, optimism persists within the sector.
speaker_0HOST
Johnson & Johnson remains hopeful about Icotide's launch momentum for psoriasis treatment, while regulatory achievements such as BARDA awarding Calio a ninety-six million dollars contract highlight biodefense preparedness critical role within national health strategies.
speaker_0HOST
Meanwhile, Pfizer's agreement with Enidia Therapeutics emphasizes big pharma's commitment to innovative protein degrader modalities.
speaker_0HOST
These developments showcase broader trends towards personalized medicine and strategic partnerships as companies navigate challenges while striving toward transformative impacts on healthcare delivery globally.
Stéphane BancelGUEST
So it's true that in the US, the funding has been challenging.
Stéphane BancelGUEST
As you said, we, we lost a big BARDA grant, uh, which was regrettable because BARDA in the past has partnered with Moderna.
Stéphane BancelGUEST
And OWS, Operation Warp Speed, was basically funded through BARDA.
Stéphane BancelGUEST
Uh, and we've done a lot of work before the pandemic, like other companies, to kind of prepare the country and prepare the world in case of bad outcomes like, like a pandemic or a big outbreak.
Stéphane BancelGUEST
Uh, the good news is we work with other agencies like SEPI in the UK to be able to keep that study going.